These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7148760)

  • 21. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine.
    Gow R; Bradbear R; Francis P; Shepherd R
    Lancet; 1981 Nov; 2(8255):1071-4. PubMed ID: 6118524
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of a novel pancreatic enzyme replacement therapy in pancreatic insufficient subjects with cystic fibrosis.
    Borowitz D; Goss CH; Limauro S; Konstan MW; Blake K; Casey S; Quittner AL; Murray FT
    J Pediatr; 2006 Nov; 149(5):658-662. PubMed ID: 17095338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro studies of microsphere pancreatic supplements.
    Littlewood JM; Kelleher J; Walters MP; Johnson AW
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
    Francisco MP; Wagner MH; Sherman JM; Theriaque D; Bowser E; Novak DA
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):79-83. PubMed ID: 12142815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High- versus low-lipase acid-resistant enzyme preparations in cystic fibrosis: a crossover randomized clinical trial.
    Lancellotti L; Cabrini G; Zanolla L; Mastella G
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):73-8. PubMed ID: 8788291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis.
    Amarri S; Harding M; Coward WA; Evans TJ; Weaver LT
    Arch Dis Child; 1997 Apr; 76(4):349-51. PubMed ID: 9166030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New modalities in the treatment of exocrine pancreatic insufficiency in cystic fibrosis.
    Heijerman HG
    Neth J Med; 1992 Oct; 41(3-4):105-9. PubMed ID: 1470278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two enteric coated microspheres in cystic fibrosis.
    Williams J; MacDonald A; Weller PH; Fields J; Pandov H
    Arch Dis Child; 1990 Jun; 65(6):594-7. PubMed ID: 2198848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase.
    Cho YW; Aviado DM
    J Clin Pharmacol; 1981; 21(5-6):224-37. PubMed ID: 7021605
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of two forms of enteric-coated pancrelipase In six teenagers with cystic fibrosis.
    Warwick WJ; Budd JR
    Clin Ther; 1982; 5(1):15-20. PubMed ID: 7127365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis.
    Durie PR; Bell L; Linton W; Corey ML; Forstner GG
    Gut; 1980 Sep; 21(9):778-86. PubMed ID: 7429342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency.
    Brugge WR; Goldberg HJ; Burke CA; Depping BJ
    Dig Dis Sci; 1988 Oct; 33(10):1226-32. PubMed ID: 3168695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malabsorption in cystic fibrosis: mechanisms and treatment.
    Bouquet J; Sinaasappel M; Neijens HJ
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S30-5. PubMed ID: 3404359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis.
    Mitchell EA; Quested C; Marks RE; Pinnock RE; Elliott RB
    Aust Paediatr J; 1982 Jun; 18(2):114-7. PubMed ID: 6923744
    [No Abstract]   [Full Text] [Related]  

  • 35. Incidence of distal intestinal obstruction syndrome in cystic fibrosis.
    Rosenstein BJ; Langbaum TS
    J Pediatr Gastroenterol Nutr; 1983 May; 2(2):299-301. PubMed ID: 6553601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrase MT12 and Ultrase MT20 in the treatment of exocrine pancreatic insufficiency in cystic fibrosis: safety and efficacy.
    Konstan MW; Stern RC; Trout JR; Sherman JM; Eigen H; Wagener JS; Duggan C; Wohl ME; Colin P
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1365-71. PubMed ID: 15606399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cimetidine on maldigestion in cystic fibrosis.
    Cox KL; Isenberg JN; Osher AB; Dooley RR
    J Pediatr; 1979 Mar; 94(3):488-92. PubMed ID: 423042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enzyme therapy for malabsorption in exocrine pancreatic insufficiency.
    Roberts IM
    Pancreas; 1989; 4(4):496-503. PubMed ID: 2668933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic enzyme replacement therapy.
    Morrow JD
    Am J Med Sci; 1989 Nov; 298(5):357-9. PubMed ID: 2683774
    [No Abstract]   [Full Text] [Related]  

  • 40. International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
    Borowitz D; Stevens C; Brettman LR; Campion M; Chatfield B; Cipolli M;
    J Cyst Fibros; 2011 Dec; 10(6):443-52. PubMed ID: 21831726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.